Equitable Mackenzie Ivy Canadian Balanced
Share 
Fund Profile
January 31, 2026
Fund Overview
The objective of the segregated fund is to invest in units of the Mackenzie Ivy Canadian Balanced Fund or a substantially similar fund. The underlying fund objective is to seek capital growth and current income by investing primarily in a combination of Canadian equities and fixed-income securities.
Risk Rating
This fund's risk rating is Low to Medium
As of November 30, 2025
Top 10 Holdings (%)
As of November 30, 2025
Growth of $10,000
As of January 31, 2026
For the period 04/30/2017 through 01/31/2026 with $10,000 CAD investment, The value of the investment would be $15,168
Calendar Return (%)
As of January 31, 2026
| Period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 10.51 | 13.18 | 9.86 | -6.03 | 14.21 | -2.37 | 13.34 | -7.17 | - | - |
| Quartile | 3 | 2 | 2 | 2 | 2 | 4 | 3 | 3 | - | - |
Compound Return (%)
As of January 31, 2026
| Period | 1 mth | 3 mths | 6 mths | 1 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|---|---|
| Fund | -2.24 | -0.71 | 2.85 | 4.19 | 9.03 | 7.81 | - |
| Quartile | 4 | 4 | 4 | 3 | 2 | 3 | - |
Fund Information
| Description | Guarantee Fee | NL | NL-CB | NL-CB5 | DSC | LL |
|---|---|---|---|---|---|---|
| Investment Class (75/75) | - | ELC754 | ELC3054 | ELC5054 | ELC654 | ELC1254 |
| Estate Class (75/100) | 0.30% | ELC954 | ELC3154 | ELC5154 | ELC854 | ELC1354 |
| Protection Class (100/100) | 0.60% | ELC1154 | ELC3254 | ELC5254 | ELC1054 | ELC1454 |
| Available for new sales | Not available for new sales | |||||
Other Fund Information
Product Availabilty
Pivotal Select (75/75, 75/100, 100/100)
Date of Inception:
May 2017
Net Asset Value per Unit:
$15.45 (02/09/2026)
Change: $0.04 (0.26%)
Estimated Management
Expense Ratio (MER)†:
2.85%
Fund Category
Canadian Equity Balanced
Portfolio Manager
Mackenzie Financial Corporation
Investment Style
Equity
Market Capitalization: Large
Fund Style: Growth
Fixed Income
Duration: Long
Credit Rating: Med
Performance Chart
Summary
For the period 04/30/2017 through 01/31/2026 with $10,000 CAD investment
Total returns performance
51.68%
Last price
$15.17 CAD
as of market close 01/31/2026
Value of $10,000 investment
$15,167.67 CAD
